January 22 – Year-end report 2024
Alligator hosted a webinar on Wednesday, January 22, at 3 p.m. CET for investors, analysts and media, where CEO Søren Bregenholt and CFO Johan Giléus presented and commented on the Year-end report, which was followed by a Q&A session.
The call was held in English and can be requested through the link below.
LATEST NEWS
Alligator Bioscience Announces Continued Encouraging Overall Survival Benefit for Mitazalimab
Results show a 24-month survival rate of 29.4% for mitazalimab in combination with mFOLFIRINOX, triple that of chemotherapy alone Topline da …
Notice of extraordinary general meeting in Alligator Bioscience AB
The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedis …
The Board of Directors of Alligator Bioscience propose a reverse share split of ordinary shares
The Board of Directors of Alligator Bioscience AB (“Alligator Bioscience” or the ”Company”) proposes that an Extraor …